Filing Details
- Accession Number:
- 0001585364-15-000227
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-12-30 15:18:49
- Reporting Period:
- 2015-03-13
- Filing Date:
- 2015-12-30
- Accepted Time:
- 2015-12-30 15:18:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1585364 | Perrigo Co Plc | PRGO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1242215 | C Joseph Papa | C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010 | Ceo | Yes | Yes | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2015-12-28 | 10,183 | $58.82 | 129,598 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2015-12-28 | 8,623 | $146.99 | 120,975 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2015-12-28 | 1,560 | $147.49 | 119,415 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2015-03-13 | 900 | $0.00 | 118,515 | No | 4 | G | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | G | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Employee Stock Option Right to Buy | Disposition | 2015-12-28 | 10,183 | $0.00 | 10,183 | $58.82 |
| Ordinary Shares | Restricted Stock Units | Acquisiton | 2015-12-28 | 10,285 | $0.00 | 10,285 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-08-19 | No | 4 | M | Direct | |
| 10,285 | 2017-12-28 | 2017-12-28 | No | 4 | A | Direct |
Footnotes
- This transaction was effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on 11/18/2015. This 10b5-1 sales plan will expire on the close of business 6/21/2016.
- Price is a weighted average. Actual priced received ranged from $146.37 - $147.37. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- Price is a weighted average. Actual priced received ranged from $147.38 - $147.53. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- Exercisable in 3 equal annual installments beginning 8/19/11.
- Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.
Billionaire Hedge Funds
